AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-73171681/methinone-enkephalin-increases-immune.html" title="Facts and information about Methinone Enkephalin Increases Immune Cell Count.(Brief Article)">Methinone Enkephalin Increases Immune Cell Count.(Brief Article)</a>

Close Set up an RSS feed that alerts you when new articles from Vaccine Weekly are available.

Frequently asked questions about RSS feeds

Methinone Enkephalin Increases Immune Cell Count.(Brief Article)

Vaccine Weekly

| April 18, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 APR 18 - (NewsRx.com & NewsRx.net) --

Researchers with Vector Medical Technologies, Inc., reported study results demonstrating the company's Methinone enkephalin vaccine increases numbers of T cells and natural killer cells in HIV patients.

Nicholas P. Plotnikoff, PhD, professor of Pharmacology at the University of Illinois Medical Center in Chicago, presented his findings regarding Methinone enkephalin ("Met-enkephalin"), in his presentation of "Met-enkephalin, therapeutic AIDS vaccine," on April 4, 2001, at a meeting of the American Association of Immunologists.

Plotnikoff, also an executive at Vector, and his research team are conducting Phase II clinical trials in human beings that have shown that Met-enkephalin strengthens and dramatically increases the number of killer T cells that destroy invading viruses, specifically HIV. Plotnikoff et al. have demonstrated that it is possible to treat HIV infected patients with Met-enkephalin and thereby increase the number of T cells/killer cells that destroy HIV with no detrimental side effects ...

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


Misdiagnosis of measles negatively impacts health workers' confidence.: Newspaper article from: Vaccine Weekly May 12, 2004 700+ words
...total of 91% of children met the clinical case definition. Among those who met the clinical case definition...article was prepared by Vaccine Weekly editors from staff and...reports. Copyright 2004, Vaccine Weekly via NewsRx.com &...


DNA-based vaccines being developed to battle bioterrorism.: Newspaper article from: Vaccine Weekly February 25, 2004 700+ words
...fibrosis." "While gene therapy has met with limited success and still has...Immunotherapy. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net...


Bush administration praises World Bank efforts to meet poverty goals.: Newspaper article from: Vaccine Weekly July 14, 2004 700+ words
...NewsRx.net) -- The World Bank has met poverty reduction goals in the areas...education. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net...


Immunization with hepatitis C core gene triggers T-cell response.: Newspaper article from: Vaccine Weekly July 14, 2004 700+ words
...core (HCV-C) by DNA immunization met serious difficulties in optimizing...Virology. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net...


Current concepts and future prospects for Alzheimer disease vaccines.: Newspaper article from: Vaccine Weekly May 5, 2004 700+ words
...amenable to any kind of therapy would have met with considerable skepticism. Yet...Neuroscience. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net...


Hepatitis A vaccine provides immune memory 12 years after primary course.: Newspaper article from: Vaccine Weekly February 25, 2004 700+ words
...antibodies." "All but one subject met pre-defined criteria for anamnestic...Virology. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net...


Alliance to advance development of botulinum toxin vaccines.: Newspaper article from: Vaccine Weekly July 14, 2004 700+ words
...Select Committee on Homeland Security met on June 3 of this year, and underscored...toxin. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net...


Positive progress reported on powder vaccine delivery technology.: Newspaper article from: Vaccine Weekly June 23, 2004 700+ words
...advantages of nasal immunization are met by the GelVac powder system and are...infections." This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net...


FluBlOk cell-culture influenza vaccine meets clinical trial primary endpoints.: Newspaper article from: Vaccine Weekly May 26, 2004 700+ words
...FluBlOk cell-culture influenza vaccine met its two primary endpoints. The trial...vaccines. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net...


First stage of phase 2 study for non-small cell lung cancer completed.: Newspaper article from: Vaccine Weekly December 29, 2004 700+ words
...established tumor response criteria have been met, allowing the company to continue...adjuvants. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net...

For more facts and information, see all results

Source: HighBeam Research, Methinone Enkephalin Increases Immune Cell Count.(Brief Article)